- BofA May Face $12 Billion Credit Cards Charge: KBW
- Bernanke: May Need to Tighten to Prevent Inflation
- California Governor and Lawmakers Reach Budget Deal
- Roubini: Recovery From Recession Will Be 'Very Ugly'
- Some China Universities Inflate Graduate Jobs Data
- Tuesday Look Ahead: Earnings May Trump Bernanke
- UK Financial Watchdog Issues Bonus Warning
- Deutsche Bank Fires 2 Execs in Spying Probe: Report
- SEC Seeks to Rein In Stanford Receiver
- Jets Owner Says New Stadium Will Be Sold Out
- Toshiba Feeling the Blu's; Apple Next?
- Tech Stocks vs ETFs: Earnings Season Strategies
- CNBC’s Sports Twitter Rankings (July ’09)
- Toyota's New U.S. Boss: 'Time to Get Close to The Customer'
- Art Cashin: My Take on Goldman's S&P Call
- Lenny Dykstra, Michael Jackson, And Goldman Sachs is Running The Country - Your Emails
- Secular Bear Market For Another 10 Years: Strategist
- Lodging Losses Mount
- Budget decisions could fuel political backlash
- Bernanke preps for hot seat on bailouts, recovery
- Nordea posts 11 pct drop in 2Q net, raises outlook
- VC investments plunge 51 pct to $3.7 billion in 2Q
- China says profit at state companies down
- Growth slumps in Chinese boomtown Dongguan
- 2-door small cars get good marks in crash tests
- Details of agreement to close California deficit
- House panel OKs new long-term care program
Amgen appoints Harvard business professor to board
THOUSAND OAKS, Calif. - Biotechnology company Amgen Inc. said Friday that Rebecca Henderson has been appointed to the board of directors.
Henderson, 48, recently became a professor at Harvard Business School and has been a director at IDEXX Laboratories Inc. since 2003. Amgen said her specialties include technology strategy and strategic problems faced by companies in high technology industries. She is also a research associate at the National Bureau of Economic Research.
Her appointment expands the size of Amgen's board to 13.
Amgen shares lost 32 cents to close at $57.81 Friday.
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.



